Cargando…
Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrier
The study of capture and processing of antigens (Ags) by intestinal epithelial cells is very important for development of new oral administration systems. Efficient oral Ag delivery systems must resist enzymatic degradation by gastric and intestinal proteases and deliver the Ag across biological bar...
Autores principales: | Coria, Lorena M., Risso, Gabriela S., Guaimas, Francisco F., Ferrero, Mariana C., Bruno, Laura, Pasquevich, Karina A., Cassataro, Juliana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329890/ https://www.ncbi.nlm.nih.gov/pubmed/30496771 http://dx.doi.org/10.1016/j.jconrel.2018.11.025 |
Ejemplares similares
-
U-Omp19 from Brucella abortus Is a Useful Adjuvant for Vaccine Formulations against Salmonella Infection in Mice
por: Risso, Gabriela S., et al.
Publicado: (2017) -
Omp19 Enables Brucella abortus to Evade the Antimicrobial Activity From Host's Proteolytic Defense System
por: Pasquevich, Karina A., et al.
Publicado: (2019) -
U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge
por: Coria, Lorena M., et al.
Publicado: (2020) -
A disordered region retains the full protease inhibitor activity and the capacity to induce CD8(+) T cells in vivo of the oral vaccine adjuvant U-Omp19
por: Laura Darriba, M., et al.
Publicado: (2022) -
Unlipidated Outer Membrane Protein Omp16 (U-Omp16) from
Brucella
spp. as Nasal Adjuvant Induces a
Th1 Immune Response and Modulates the Th2 Allergic Response to Cow’s Milk
Proteins
por: Ibañez, Andrés E., et al.
Publicado: (2013)